MAPT and Alzheimer disease: For instance, in a triple-transgenic AD (3xTg-AD) mouse model, many key pathological features of AD, such as Aβ plaque formation, tau protein hyperphosphorylation, synaptic dysfunction, and microglial activation, appear to be influenced by the GM [39].